☆ 4.8 Editorial Material

Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies

FRONTIERS IN IMMUNOLOGY (2021)

Journal

FRONTIERS IN IMMUNOLOGY

Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA

DOI: 10.3389/fimmu.2021.770275

Keywords

chronic inflammatory diseases; spondyloarthritis; interleukin-23; interleukin-17; psoriasis

Categories

Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Immunology

Interleukin-17 Links Inflammatory Cross-Talks Between Comorbid Psoriasis and Atherosclerosis

Yan Wang, Jinxin Zang, Chen Liu, Zhongrui Yan, Dongmei Shi

Summary: Psoriasis is associated with an increased risk of cardiovascular disease. Clinical studies have shown that IL-17A inhibitors can effectively improve both psoriasis and atherosclerosis symptoms, suggesting that IL-17A may play a crucial role in the comorbidity of these two diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors

Yu-Huei Huang, Lun-Ching Chang, Ya-Ching Chang, Wen-Hung Chung, Shun-Fa Yang, Shih-Chi Su

Summary: Alterations in gut microbiota composition and microbial-encoded metabolic pathways were observed in patients with psoriasis, and the impact of biologics on shaping gut microbiota was explored in this study. The results showed that the gut microbial compositions changed during the treatment period, and the relative abundance of individual taxa differed between patients receiving different inhibitors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Medicine, General & Internal

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study

Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti-Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano

Summary: This study aimed to compare the efficacy of IL-17 and IL-23 inhibitors in treating pustular and erythrodermic psoriasis. The results showed that IL-17 inhibitors had higher effectiveness in treating these conditions, while the efficacy of IL-23 inhibitors remains unknown.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Psoriasis-Associated Inflammatory Conditions Induce IL-23 mRNA Expression in Normal Human Epidermal Keratinocytes

Evelyn Kelemen, Eva Adam, Stella Marta Sagi, Aniko Goblos, Lajos Kemeny, Zsuzsanna Bata-Csorgo, Marta Szell, Judit Danis

Summary: Psoriasis is a chronic inflammatory skin disease influenced by both genetic and environmental factors. Increased levels of free nucleic acids in psoriatic skin are associated with IL-23 expression. The study reveals that free nucleic acids regulate IL-23 mRNA expression in epithelial keratinocytes through TLR3 receptor and specific signaling pathways, contributing to the development of an inflammatory milieu favorable for psoriatic symptoms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Immunology

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis

Runsheng Wang, Walter P. Maksymowych

Summary: The IL-23/IL-17 pathway plays a crucial role in the pathogenesis of axial spondyloarthritis, with clinical trials showing that monoclonal antibodies targeting IL-17A can improve symptoms and MRI inflammation in patients. Treatment with a bispecific antibody targeting both IL-17A and IL-17F also showed effectiveness in reducing spinal ankylosis development.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models

Mohamed Mandour, Sijia Chen, Marleen G. H. van de Sande

Summary: Spondyloarthritis (SpA) is a chronic inflammatory joint disease where the IL-23/IL-17 pathway and TNF-α cytokine play important roles in its pathogenesis. Animal models have provided new insights into molecular mechanisms at different stages of SpA, aiding in understanding disease initiation and potential therapeutic strategies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Health Care Sciences & Services

Inflammatory versus Anti-Inflammatory Profiles in Major Depressive Disorders-The Role of IL-17, IL-21, IL-23, IL-35 and Foxp3

Malgorzata Galecka, Katarzyna Blizniewska-Kowalska, Agata Orzechowska, Janusz Szemraj, Michael Maes, Michael Berk, Kuan-Pin Su, Piotr Galecki

Summary: This research study found that in depressed patients without coexisting inflammatory diseases, the gene expression levels of specific immune-inflammatory factors such as IL-17, IL-21, IL-23, and IL-35 were higher, while Foxp3 expression was lower. The duration of the disease appears to be more important than the severity of depression in relation to the expression of these genes. These findings suggest that specific inflammatory genes may play a role in the etiopathogenesis of depressive disorders.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Immunology

The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases

S. P. Deo-Gracias Berry, Camille Dossou, Ali Kashif, Niusha Sharifinejad, Gholamreza Azizi, Haleh Hamedifar, Araz Sabzvari, Zeineb Zian

Summary: This review highlights the role of IL-17 in chronic inflammation occurring in allergy, malignancy, and autoimmune diseases, and discusses the potential therapeutic approach of targeting IL-17 and/or IL-17R using monoclonal antibodies (mAbs).

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis

Kamran Ghoreschi, Anna Balato, Charlotta Enerback, Robert Sabat

Summary: Psoriasis is a chronic inflammatory disease affecting 2-3% of the global population, characterized by sharply demarcated erythematous and scaly skin lesions. The disease results from hyperproliferation and disturbed differentiation of epidermal keratinocytes provoked by immune mediators of the IL-23 and IL-17 pathway. Therapeutics targeting IL-23, IL-17, and IL-17RA have shown excellent efficacy in treating psoriasis.

LANCET (2021)

Add to Collection

Article Immunology

IL-27 attenuates IL-23 mediated inflammatory arthritis

Ritu Sarin, Ran Gu, Zahra Jalali, Emanual Maverakis, Maria G. Tsokos, Iannis E. Adamopoulos

Summary: Interleukin 27 has both pro-inflammatory and anti-inflammatory properties in autoimmunity. The anti-inflammatory effects of IL-27 are linked with inhibition of Th17 differentiation and IL-27 also inhibits IL-23-induced inflammation associated with myeloid cell infiltration in the joints and spleen. The IL-27 anti-inflammatory response is associated with reduced levels of myeloid cells in the spleen and bone marrow.

CLINICAL IMMUNOLOGY (2023)

Add to Collection

Article Dermatology

Effectiveness of anti-interleukin 23 biologic drugs in psoriasis patients who failed anti-interleukin 17 regimens. A real-life experience

Claudio Bonifati, Aldo Morrone, Antonio Cristaudo, Dario Graceffa

Summary: New biologic drugs targeting interleukin-17 have shown quick effectiveness in treating psoriasis, but there is limited real-life data on switching to biologics targeting interleukin-23 in patients who have failed previous treatments.

DERMATOLOGIC THERAPY (2021)

Add to Collection

Review Dermatology

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities

Alan Menter, Gerald G. Krueger, So Yeon Paek, Dario Kivelevitch, Iannis E. Adamopoulos, Richard G. Langley

Summary: Psoriasis is an immune-mediated inflammatory skin disease associated with inflammatory comorbidities, including increased cardiovascular risk. The IL-23/IL-17 axis plays a central role in the immunopathogenesis of psoriasis and related comorbidities, and selectively inhibiting these cytokines has significant therapeutic benefits for patients with moderate to severe plaque psoriasis.

DERMATOLOGY AND THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseases

Elham Aghamohamadi, Nastaran Asri, Aylin Odak, Mohammad Rostami-Nejad, Vahid Chaleshi, Yasaman Hajinabi, Maryam Eslami, Saeed Mohammadian Haftcheshmeh, Fahimeh Sadat Gholam-Mostafaei, Hamid Asadzadeh-Aghdaei, Andrea Masotti, Mohammad Reza Zali

Summary: The expression patterns of pro-inflammatory and anti-inflammatory cytokines in intestinal biopsy specimens of patients with celiac disease and inflammatory bowel disease were similar, but the expression of anti-inflammatory cytokines was lower in celiac disease. Understanding this regulation is important for finding therapeutic protocols.

MOLECULAR BIOLOGY REPORTS (2022)

Add to Collection

Article Health Care Sciences & Services

Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

Laura A. Lucaciu, Maria Ilies, Stefan C. Vesa, Radu Seicean, Shahida Din, Cristina Adela Iuga, Andrada Seicean

Summary: Interleukin (IL)-23 and fecal calprotectin levels were significantly elevated in severe inflammatory bowel disease (IBD), while IL-17 and C-reactive protein were associated with disease severity. IL-23 may serve as a promising novel biomarker for severe Crohn's disease, guiding clinical decision-making on biologic therapy. Identifying the main IL pathway involved in IBD severity could provide valuable insights for personalized treatment approaches.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Review Immunology

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis

Angela Ceribelli, Francesca Motta, Matteo Vecellio, Natasa Isailovic, Francesco Ciccia, Carlo Selmi

Summary: Spondyloarthritis (SpA) is a group of inflammatory musculoskeletal diseases with common genetic backgrounds, and IL-17 and IL-23 have been identified as key cytokines in its pathogenesis. Treatment options for axial SpA differ significantly from peripheral arthritis, with new therapies targeting these cytokines showing promising results for both axial psoriatic arthritis and ankylosing spondylitis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Rheumatology

The multifaceted functional role of DNA methylation in immune-mediated rheumatic diseases

Matteo Vecellio, Haijing Wu, Qianjin Lu, Carlo Selmi

Summary: Epigenetic mechanisms, particularly DNA methylation, are considered to be important in autoimmune and chronic inflammatory diseases, connecting environmental stimuli with genetic susceptibility. The causal relationship between DNA methylation and gene silencing is well established, but there is controversy in comparing DNA methylation results from different studies. Intriguing evidence comes from comparing the epigenome in clinically discordant monozygotic twins.

CLINICAL RHEUMATOLOGY (2021)

Add to Collection

Letter Rheumatology

A case of psoriatic arthritis triggered by SARS-CoV-2 infection

Lucia Novelli, Francesca Motta, Angela Ceribelli, Giacomo M. Guidelli, Nicoletta Luciano, Natasa Isailovic, Matteo Vecellio, Marta Caprioli, Nicola Clementi, Massimo Clementi, Nicasio Mancini, Carlo Selmi, Maria De Santis

RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Functional Genomic Analysis of a RUNX3 Polymorphism Associated With Ankylosing Spondylitis

Matteo Vecellio, Liye Chen, Carla J. Cohen, Adrian Cortes, Yan Li, Sarah Bonham, Carlo Selmi, Matthew A. Brown, Roman Fischer, Julian C. Knight, B. Paul Wordsworth

Summary: This study investigated the functional consequences of the single-nucleotide polymorphism rs4648889 in a putative enhancer upstream of the RUNX3 promoter associated with susceptibility to ankylosing spondylitis (AS). The results indicated that IRF5 plays a crucial role in the functions of CD8+ lymphocytes, suggesting new therapeutic targets for managing AS.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Review Immunology

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis

Matteo Vecellio, Vivien Xanath Hake, Connor Davidson, Maria Cristina Carena, B. Paul Wordsworth, Carlo Selmi

Summary: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis, with genetic predisposition playing a key role in its development. The IL-23/IL-17 axis is highlighted as important in the immunopathogenesis of PsA.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Immunology

Perspectives on the Genetic Associations of Ankylosing Spondylitis

B. Paul Wordsworth, Carla J. Cohen, Connor Davidson, Matteo Vecellio

Summary: Ankylosing spondylitis is a common form of inflammatory spinal arthritis with a complex polygenic etiology. Genetic associations with AS have been identified in regions involved in antigen presentation, Th17 responses, and macrophages/T-cells. Many associations are found in intergenic regions, reflecting functional polymorphisms regulating gene expression. Understanding these associations may lead to better insights into the pathogenic pathways of AS and potential targets for drug therapy.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis

Natasa Isailovic, Angela Ceribelli, Gilberto Cincinelli, Matteo Vecellio, Giacomo Guidelli, Marta Caprioli, Nicoletta Luciano, Francesca Motta, Carlo Selmi, Maria De Santis

Summary: Tofacitinib has a regulatory effect on B cells from patients with rheumatoid arthritis, reducing levels of inflammatory cytokines while not decreasing their production following stimulation with collagen epitopes.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Add to Collection

Article Rheumatology

MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis

Francesca Motta, Andrea Pederzani, Maria Cristina Carena, Angela Ceribelli, Paul B. Wordsworth, Maria De Santis, Carlo Selmi, Matteo Vecellio

Summary: MicroRNAs play an important role in ankylosing spondylitis and psoriatic arthritis, particularly through immunomodulation, inflammation, and bone remodeling. While research has highlighted their contribution, further confirmation of their utility as possible biomarkers is needed in larger patient cohorts.

CURRENT RHEUMATOLOGY REPORTS (2021)

Add to Collection

Review Immunology

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis

Angela Ceribelli, Francesca Motta, Matteo Vecellio, Natasa Isailovic, Francesco Ciccia, Carlo Selmi

Summary: Spondyloarthritis (SpA) is a group of inflammatory musculoskeletal diseases with common genetic backgrounds, and IL-17 and IL-23 have been identified as key cytokines in its pathogenesis. Treatment options for axial SpA differ significantly from peripheral arthritis, with new therapies targeting these cytokines showing promising results for both axial psoriatic arthritis and ankylosing spondylitis.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Allergy

The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity

Rossana Scrivo, Salvatore D'Angelo, Antonio Carriero, Chiara Castellani, Fabio Massimo Perrotta, Fabrizio Conti, Matteo Vecellio, Carlo Selmi, Ennio Lubrano

Summary: Psoriatic arthritis is a chronic inflammatory disease characterized by various symptoms and comorbidities. Its pathogenesis involves both autoinflammatory and autoimmune aspects.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2023)

Add to Collection

Editorial Material Genetics & Heredity

Editorial: Genetic Studies on Spondyloarthritis: From Disease Predictors to Therapeutic Targets

Matteo Vecellio, Fabiana Paladini, Roberta Ramonda

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Genetics & Heredity

Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3 Promoter

Carla J. Cohen, Connor Davidson, Carlo Selmi, Paul Bowness, Julian C. Knight, B. Paul Wordsworth, Matteo Vecellio

Summary: Ankylosing Spondylitis (AS) is a complex and highly heritable form of inflammatory spinal arthritis. This study investigated the effect of the rs6600247 genotype on DNA binding and chromosome looping in relation to RUNX3, a gene associated with AS.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Rheumatology

2021 GRAPPA Trainee Symposium: A Summary of Oral and Poster Presentations

April W. Armstrong, Rasika M. Reddy, Keith Colaco, Pamela A. Diaz, Raminderjit Kaur, David Simon, Matteo Vecellio, M. Elaine Husni

Summary: GRAPPA held a trainee symposium at its 2021 virtual meeting, featuring research on psoriasis and psoriatic arthritis. The report includes 5 oral presentations and 22 poster discussions.

JOURNAL OF RHEUMATOLOGY (2022)

Add to Collection

Article Immunology

Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease

Angela Ceribelli, Natasa Isailovic, Carolina Gorlino, Roberto Assandri, Matteo Vecellio, Maria De Santis, Minoru Satoh, Carlo Selmi

Summary: This study found that autoantibodies against the PDC components can be detected in rheumatic patients. These antibodies may have important value for the early diagnosis of primary biliary cholangitis (PBC).

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Immunology

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases

Maria De Santis, Francesca Motta, Natasa Isailovic, Massimo Clementi, Elena Criscuolo, Nicola Clementi, Antonio Tonutti, Stefano Rodolfi, Elisa Barone, Francesca Colapietro, Angela Ceribelli, Matteo Vecellio, Nicoletta Luciano, Giacomo Guidelli, Marta Caprioli, Clara Rezk, Lorenzo Canziani, Elena Azzolini, Luca Germagnoli, Nicasio Mancini, Ana Lleo, Carlo Selmi

Summary: The efficacy and safety of the Moderna-1273 mRNA vaccine were evaluated in patients with immune-mediated diseases under different treatments. The study found that mycophenolate treatment may impair vaccine immunogenicity, and higher doses were associated with a lower humoral response. These findings suggest the need to consider the effects of different immunotherapies when selecting a vaccination regimen.

VACCINES (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.